Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Entrada Therapeutics (TRDA) Insider Trading & Ownership

Entrada Therapeutics logo
$6.18 +0.31 (+5.28%)
As of 03:28 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Entrada Therapeutics (NASDAQ:TRDA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
8.11%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
$2.79M
Get TRDA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Entrada Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

TRDA Insider Buying and Selling by Quarter

Entrada Therapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/9/2025Kush ParmarDirectorSell27,000$7.50$202,500.00  
7/9/2025Ventures V L.P. 5AmMajor ShareholderSell20,065$7.50$150,487.50  
7/9/2025Ventures V L.P. 5AmMajor ShareholderSell6,935$7.50$52,012.50  
6/30/2025Kush ParmarDirectorSell25,000$6.81$170,250.00  
6/30/2025Ventures V L.P. 5AmMajor ShareholderSell18,578$6.81$126,516.18  
6/30/2025Ventures V L.P. 5AmMajor ShareholderSell6,422$6.81$43,733.82  
6/27/2025Kush ParmarDirectorSell75,000$6.91$518,250.00  
6/27/2025Ventures V L.P. 5AmMajor ShareholderSell55,735$6.91$385,128.85  
6/27/2025Ventures V L.P. 5AmMajor ShareholderSell19,265$6.91$133,121.15  
12/10/2024Bioventures 2018 L.P. MpmMajor ShareholderSell22,935$20.77$476,359.95  
12/2/2024Kory James WentworthCFOSell5,000$20.00$100,000.00  
11/29/2024Kory James WentworthCFOSell1,000$19.97$19,970.00  
11/13/2024Natarajan SethuramanInsiderSell2,700$20.04$54,108.00  
11/11/2024Kory James WentworthCFOSell8,637$19.98$172,567.26  
11/11/2024Natarajan SethuramanInsiderSell1,409$20.01$28,194.09  
10/16/2024Natarajan SethuramanInsiderSell600$18.00$10,800.00  
9/26/2024Nathan J DowdenCOOSell847$16.00$13,552.00  
9/9/2024Kory James WentworthCFOSell3,195$14.97$47,829.15  
9/9/2024Natarajan SethuramanInsiderSell2,642$15.09$39,867.78  
9/9/2024Nathan J DowdenCOOSell1,904$15.07$28,693.28  
9/6/2024Natarajan SethuramanInsiderSell600$15.24$9,144.00  
9/6/2024Nathan J DowdenCOOSell399$15.19$6,060.81  
(Data available from 1/1/2013 forward)

TRDA Insider Trading Activity - Frequently Asked Questions

The list of insiders at Entrada Therapeutics includes Bioventures 2018 L.P. Mpm, Dipal Doshi, Kory James Wentworth, Kush Parmar, Natarajan Sethuraman, Nathan J Dowden, Nerissa Kreher, Peter S Kim, and Ventures V L.P. 5Am. Learn more on insiders at TRDA.

8.11% of Entrada Therapeutics stock is owned by insiders. Learn more on TRDA's insider holdings.

The following insider purchased TRDA shares in the last 24 months: Peter S Kim ($151,226.80).

Insiders have purchased a total of 11,172 TRDA shares in the last 24 months for a total of $151,226.80 bought.

The following insiders have sold TRDA shares in the last 24 months: Bioventures 2018 L.P. Mpm ($476,359.95), Dipal Doshi ($169,286.00), Kory James Wentworth ($541,153.63), Kush Parmar ($891,000.00), Natarajan Sethuraman ($326,361.12), Nathan J Dowden ($61,398.93), Nerissa Kreher ($12,024.16), and Ventures V L.P. 5Am ($891,000.00).

Insiders have sold a total of 343,353 Entrada Therapeutics shares in the last 24 months for a total of $3,368,583.79 sold.

Entrada Therapeutics Key Executives


Related Companies
Insider Tracking Tools
Insider Trading By Country
Latest Articles

This page (NASDAQ:TRDA) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners
Silver’s Still Under $35… For Now.
Silver is trading around $33—but insiders are betting on a $70 breakout by year’s end. With supply shrinkin...
GoldenCrest Metals | Sponsoredtc pixel
What Steve Bannon revealed about Trump’s gold play
A Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...
Reagan Gold Group | Sponsoredtc pixel
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
Altucher: It Looks Like My Trump prediction is coming true
New Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...
Paradigm Press | Sponsoredtc pixel
BREAKING: The House just passed 3 pro-crypto bills!
The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...
Crypto 101 Media | Sponsoredtc pixel
Retire Comfortably with These New Monthly Income ETFs?
Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...
Investors Alley | Sponsoredtc pixel
When the levee breaks
The U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...
Porter & Company | Sponsoredtc pixel